Is Cellectar Biosciences, Inc. technically bullish or bearish?

As of 8 September 2025, the technical trend for Cellectar Biosciences, Inc. has changed from mildly bullish to bullish. The current stance is bullish, with key indicators supporting this view being the weekly and monthly RSI readings, both of which are bullish. However, the MACD remains mildly bullish on both weekly and monthly time frames, indicating some caution. The Dow Theory shows a mixed picture with a mildly bullish weekly signal but a bearish monthly signal.
Despite the bullish trend, the stock has underperformed significantly compared to the S&P 500 over various periods, with a 1-year return of -91.29% versus the S&P 500's 17.14%, and a staggering 5-year return of -98.49% compared to the S&P 500's 96.61%. This suggests that while the current technical indicators are bullish, the overall performance remains weak relative to the benchmark.